Company: BIVIW
Filing Date: 2025-08-08
Form Type: 424B5
Source: 0001520138-25-000247
Chunk: 209

Company: BIOVIE INC.
Filing Date: 2025-08-08
Form: 424B5
Chunk 209
---
”) to purchase 600,000 shares of Common Stock, and warrants to purchase up to
1,960,800 shares of Common Stock (the “September Common Warrants”) at a combined public offering price of $1.53 per share,
or September Pre-funded Warrant, and the associated September Common Warrant. 265,000 September Pre-funded Warrants were exercised in
the three months ended September 30, 2024 and reflected on the condensed statement of changes in stockholders’ equity as a component
of proceeds from issuance of common stock. The September Common Warrants have an exercise price of $ 1.53per share and were immediately exercisable upon issuance and will expire on the fifth anniversary date of the original issuance date.The gross proceeds to the Company from the September 2024 Offering were approximately $3.0 million, before deducting placement
agent fees and offering expenses of approximately $747,000. Additionally, upon closing, the Company issued the placement agent warrants
(“September Placement Agent’s Warrants”) to purchase 98,040 shares of Common Stock exercisable at a per share price
of $1.91, which was equal to 125% of the public offering price per share. The September Placement Agent’s Warrants are exercisable
during a five-year period commencing 180 days from September 25, 2024.

F-37

In October 2024, the Company closed three registered
direct offerings totaling 8,256,000 shares of its common stock, par value $0.0001 per share, and two concurrent private placements of
warrants to purchase up to 7,110,000 shares of Common Stock (the “October Common Warrants”) priced at-the-market under Nasdaq
rules at prices ranging from $1.50 to $2.83 per share (the “October Offerings”). The October Common Warrants have exercise prices ranging from $ 1.37to $ 2.12per share and are exercisable beginning six months following issuance and will expire on the fifth anniversary date of the original issuance dates.The gross proceeds to the Company from the
October Offerings totaled approximately $15.9 million, before deducting placement agent fees and offering expenses of approximately $2.5
million. Additionally, upon closing of the October Offerings, the Company issued placement agent warrants (the “October Placement
Agent’s Warrants”) to purchase 412,800 shares of Common Stock in the aggregate exercisable at a per share